The body’s inflammatory response to fight infections and in tissue repair processes is crucial for normal functioning of the body. Yet, if not controlled, it can cause severe injury to the human body, as occurs during cytokine storm, a potentially fatal chain reaction that can be generated, for example, following serious forms of infection, such as SARS-CoV-2 or sepsis.
Despite the progress in developing novel strategies to manage the immune response, the drugs that could efficiently prevent a steep surge in cytokines are still lacking.
We have identified a known compound that by blocking the membrane receptor PAR-2, is able to mitigate the cytokine storm, especially in patients with severe infections such as those due to COVID-19.

TRL (Technology Readiness Level)

Lead Optimization/Preclinical

Inventors

Patrizia
Pontisso

Alessandra
Biasiolo

Andrea
Martini

Laura
Cendron

Monica
Chinellato

Santina
Quarta

Mariagrazia
Ruvoletto

Cristian
Turato

Gianmarco
Villano

Download the brochure

  • siRNAEEC – Novel treatment to mitigate the Ectrodactyly-Ectodermal dysplasia- Clefting (EEC) associated blindness

    The Ectrodactyly-Ectodermal dysplasia-Clefting (EEC) syndrome is a rare genetic disorder due to mutations in the p63 gene and characterized by limb defects, orofacial clefting, ectodermal dysplasia, and ocular surface defects that lead to the loss of vision. Currently no specific[...]

  • A novel treatment for diabetic ulcers

    Diabetic chronic ulcers, a common complication of diabetes, are significant cause of morbidity and mortality in the Western world. Despite the considerable medical need, currently no specific and efficacious treatment for diabetic -and other chronic- ulcers exist. This is in[...]

  • Use of small molecules to rescue folding defective proteins

    The use of CFTR (cystic fibrosis transmembrane conductance regulator) correctors for the treatment of rare and devastating genetic muscular diseases, namely sarcoglycanopathies and Brody myopathy, is the object of this invention. Sarcoglycanopathies and Brody myopathy are rare inherited striated muscle[...]

Subscribe to newsletter

Follow the activities promoted by UniSMART Foundation